FendX Technologies, Inc, led by CEO Carolyn Myers, is developing nanotechnology solutions for infection control. Their REPELWRAP film, spray formulation, and catheter coating aim to prevent the spread of viruses and infectious diseases. Collaborating with Dunmore International Corp. and McMaster University, FendX is optimizing the scale-up of REPELWRAP film for real-world testing. The spray formulation, licensed from McMaster, complements existing hygiene practices by repelling pathogens on surfaces continuously. The company's innovations offer versatility and potential in various industries, including healthcare and beyond. A collaborative research agreement with McMaster focuses on coating catheters to reduce biofilm formation and blood adhesion, addressing complications associated with long-term catheter use. These advancements signify promising strides in infection prevention and control.
FendX Technologies, Inc, led by CEO Carolyn Myers, is developing nanotechnology solutions for infection control. Their REPELWRAP film, spray formulation, and catheter coating aim to prevent the spread of viruses and infectious diseases. Collaborating with Dunmore International Corp. and McMaster University, FendX is optimizing the scale-up of REPELWRAP film for real-world testing. The spray formulation, licensed from McMaster, complements existing hygiene practices by repelling pathogens on surfaces continuously. The company's innovations offer versatility and potential in various industries, including healthcare and beyond. A collaborative research agreement with McMaster focuses on coating catheters to reduce biofilm formation and blood adhesion, addressing complications associated with long-term catheter use. These advancements signify promising strides in infection prevention and control.